News FDA clears subcutaneous Keytruda in a boost to MSD MSD's Keytruda will soon be available as a subcutaneous injection, improving convenience for patients and defending it from a looming patent loss.
News COVID-19 vaccine support reined back by ACIP The CDC's vaccine committee reduced some support for COVID-19 vaccines, but did not go as far as some might have feared in limiting access.
News ACIP pushes back vote on hepatitis B vaccine ACIP has agreed to push back a vote on recommendations for a birth dose of hepatitis B vaccine, as panellists were unhappy with the proposed wording.
News ACIP votes against first-dose MMRV for under 4s ACIP votes down recommendation allowing MSD's MMRV shot as an option for children under four, but there's confusion about the coverage implications.
News Monarez: Kennedy has plan to change child vaccine schedule Fired CDC chief Susan Monarez told the Senate HELP committee today that HHS Secretary Kennedy has a plan to change to child vaccinations this month.
News PHTI delivers its verdict on DHTs for opioid use disorder Digital health tech for opioid use disorder can be as effective as regular care, but it doesn't expand access and may increase the cost of care.
News Otsuka grows in neuroplastogens with $1.225bn Transcend buy Otsuka has agreed to acquire Transcend Therapeutics and its MDMA-based neuroplastogen drug candidate for PTSD, heading for phase 3 trials.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.